A Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Booster Dose of a Group B Streptococcus 6-Valent Polysaccharide Conjugate Vaccine in Healthy Adults
A Phase 2, Open-Label Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Booster Dose of a Group B Streptococcus 6-Valent Polysaccharide Conjugate Vaccine (GBS6) in Healthy Adults
Category & Conditions: Vaccine-related Conditions
Medicine: PF-06760805
ClinicalTrials.gov Identifier (NCT): NCT04258995
Protocol ID: C1091007
PrintDownloadOpen Plain Language Summary Result: Click here